Chemours vs Ingevity

Chemours and Ingevity are compared on this page, outlining business models, financial performance, and market context in a neutral, accessible way to support understanding. Educational content, not financial advice.

Chemours and Ingevity are compared on this page, outlining business models, financial performance, and market context in a neutral, accessible way to support understanding. Educational content, not fi...

Comparison Snapshot

Key Financial Metrics

CC

Metric

NGVT

$2.37B

Market Cap

$2.49B

0.23%

Potential Profit

3.17%

Buy

Analyst Rating

Buy

Investment Analysis

Chemours

CC

Pros

Strong demand for Opteon™ refrigerant products supports operational performance despite challenging macroeconomic conditions.
Attractive valuation with discount cash flow analysis suggesting the stock is undervalued by approximately 33%, offering potential value for long-term investors.
Analyst consensus rates Chemours as a 'Buy' with an average price target implying a potential 35% upside from current levels.

Considerations

Q3 2025 earnings significantly missed estimates, with EPS of $0.20 versus $0.26 expected, highlighting near-term profitability challenges.
Ongoing environmental litigation and leadership changes introduce uncertainty and have contributed to a 40% stock decline over the past year.
Net income remains negative with reported losses, reflecting continued operational and financial headwinds despite revenue generation.

Ingevity

NGVT

Pros

Diverse operations spanning specialty chemicals, advanced polymer technologies, and automotive carbon products provide multiple growth avenues.
Primary revenue generation from North America markets supports operational stability in a large and developed economy.
Solid balance sheet metrics including a current ratio of 2.00 indicate good short-term liquidity management.

Considerations

Relatively low quick ratio of 0.69 signals potential challenges in meeting immediate liabilities without inventory sales.
Negative interest coverage ratio suggests challenges in covering interest expenses, indicating leveraged financial structure.
Smaller market capitalization and valuation multiples reflect limited scale and potential growth constraints compared to larger peers.

Related Market Insights

Chemical Sector Shake-Up: Riding Berkshire's Ripple

Berkshire Hathaway's $10B OxyChem bid signals confidence in the chemical sector. Discover investment opportunities & ripple effects. Invest commission-free with Nemo.

Aimee Silverwood | Financial Analyst

October 1, 2025

Read Insight

The Unglamorous Giants: Why Society's Necessary Evils Make Compelling Investments

These companies handle society's dirty work—waste management, hazardous chemicals, and industrial cleanup—creating defensive investment opportunities with inelastic demand and regulatory moats.

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

Related Market Insights

Chemical Sector Shake-Up: Riding Berkshire's Ripple

Berkshire Hathaway's $10B OxyChem bid signals confidence in the chemical sector. Discover investment opportunities & ripple effects. Invest commission-free with Nemo.

Aimee Silverwood | Financial Analyst

October 1, 2025

Read Insight

The Unglamorous Giants: Why Society's Necessary Evils Make Compelling Investments

These companies handle society's dirty work—waste management, hazardous chemicals, and industrial cleanup—creating defensive investment opportunities with inelastic demand and regulatory moats.

Aimee Silverwood | Financial Analyst

July 25, 2025

Read Insight

About The Companies

Chemours (CC)

Chemours Company (CC) is a US-based chemicals manufacturer known for titanium dioxide (TiO2) pigments, fluoroproducts (including refrigerants and specialty fluorochemicals) and performance chemicals. With a market capitalisation around $2.0 billion, the group serves coatings, automotive, industrial and refrigeration markets worldwide. Key drivers include global industrial and construction activity, raw-material and energy costs, product mix and pricing for commodity chemicals. Investors should note exposure to cyclical end markets, volatile input costs and material regulatory and environmental scrutiny associated with certain fluorochemicals. The company has pursued operational improvements and portfolio management to stabilise cash flow, but outcomes can vary. This summary is for educational purposes only and not personalised investment advice; values can rise and fall and past performance does not guarantee future results. Consider your risk tolerance and seek professional advice if unsure about suitability.

Ingevity (NGVT)

Ingevity Corporation (NGVT) is a US-based specialty chemicals and materials company with a market capitalisation of about $2.04 billion. It manufactures engineered and activated carbon, performance additives and specialty chemicals used across automotive emission control, industrial filtration, water purification and select energy applications. Revenue is generated from sales of filtration media, additives and chemical intermediates to OEMs, municipal utilities and industrial customers. Investors may watch Ingevity for exposure to structural trends such as tighter emissions standards, growing water-treatment needs and potential demand in energy storage materials, though results can be cyclical and sensitive to commodity costs, capacity utilisation and regulatory changes. Strengths include technical expertise, customer relationships and focused capital investment; risks include raw-material volatility, competition, execution on expansion projects and environmental liabilities. This is general educational information, not personalised investment advice — always review the latest company filings and consider your own objectives and risk tolerance.

Which Baskets Do They Appear In?

Chemical Sector: Berkshire's $10B Acquisition Impact

Berkshire Hathaway's potential $10 billion acquisition of Occidental's OxyChem unit signals a major investment in the industrial chemical sector. This move could create ripple effects, presenting opportunities for other chemical manufacturers who stand to gain from shifts in the market.

Published: October 1, 2025

Explore Basket

Necessary Evils Portfolio

These companies provide the essential infrastructure and services our society can't function without, even if they're not always popular. Carefully selected by our analysts, these stocks offer defensive stability thanks to their non-negotiable role in the global economy.

Published: June 17, 2025

Explore Basket

Which Baskets Do They Appear In?

Chemical Sector: Berkshire's $10B Acquisition Impact

Berkshire Hathaway's potential $10 billion acquisition of Occidental's OxyChem unit signals a major investment in the industrial chemical sector. This move could create ripple effects, presenting opportunities for other chemical manufacturers who stand to gain from shifts in the market.

Published: October 1, 2025

Explore Basket

Necessary Evils Portfolio

These companies provide the essential infrastructure and services our society can't function without, even if they're not always popular. Carefully selected by our analysts, these stocks offer defensive stability thanks to their non-negotiable role in the global economy.

Published: June 17, 2025

Explore Basket

Discover More Comparisons

Chemours vs Ramaco Resources

Chemours Company, The vs Ramaco Resources

Chemours vs FMC

Ashland vs Ingevity

Chemours vs Ingevity

Comparison Snapshot